Literature DB >> 9628219

Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay.

R L de Swart1, H W Vos, F G UytdeHaag, A D Osterhaus, R S van Binnendijk.   

Abstract

A FACS-measured immunofluorescence assay was developed for the detection of antibodies directed against the hemagglutinin (H) and fusion (F) glycoproteins of measles virus (MV). Human melanoma cell lines transfected with either the MV H or F genes, which showed a high surface expression of the respective proteins in their native conformation, were used as target cells. The cells were incubated with diluted plasma samples, and stained subsequently with FITC-conjugated secondary antibodies. The FACS-measured fluorescence signals correlated directly with the amount of specific immunoglobulins over a wide concentration range. The use of different conjugates enabled the separate detection of MV-specific IgG, IgM, IgA and IgG subclasses, with relatively low backgrounds. Hemagglutinin-specific IgG, IgM and IgA fluorescence signals were shown to correlate well with MV-specific IgG ELISA titers and MV-specific IgM or IgA capture ELISA OD450-values, respectively. The polyclonal conjugates with specificity for human immunoglobulins offered sufficient cross-reactivity to detect MV-specific IgG, IgM and IgA in plasma samples of cynomolgus macaques, making this technique a useful tool for studying serological responses in vaccination and challenge experiments in non-human primate models.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628219     DOI: 10.1016/s0166-0934(97)00188-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  14 in total

1.  Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.

Authors:  Rik L de Swart; Selma Yüksel; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.

Authors:  Miguel Ángel Muñoz-Alía; Claude P Muller; Stephen J Russell
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

3.  Measles virus-specific antibody levels in Sudanese infants: a prospective study using filter-paper blood samples.

Authors:  S A Ibrahim; A Abdallah; E A Saleh; A D M E Osterhaus; R L De Swart
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

4.  Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

Authors:  K J Stittelaar; L S Wyatt; R L de Swart; H W Vos; J Groen; G van Amerongen; R S van Binnendijk; S Rozenblatt; B Moss; A D Osterhaus
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum.

Authors:  H S el Mubarak; M W Van De Bildt; O A Mustafa; H W Vos; M M Mukhtar; J Groen; A M el Hassan; H G Niesters; S A Ibrahim; E E Zijlstra; T F Wild; A D Osterhaus; R L De Swart
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.

Authors:  Linda J Rennick; Rory D de Vries; Thomas J Carsillo; Ken Lemon; Geert van Amerongen; Martin Ludlow; D Tien Nguyen; Selma Yüksel; R Joyce Verburgh; Paula Haddock; Stephen McQuaid; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Measles virus targets DC-SIGN to enhance dendritic cell infection.

Authors:  Lot de Witte; Marion Abt; Sibylle Schneider-Schaulies; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin.

Authors:  E Marquet-Blouin; F B Bouche; A Steinmetz; C P Muller
Journal:  Plant Mol Biol       Date:  2003-03       Impact factor: 4.076

9.  Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.

Authors:  Rory D de Vries; Martin Ludlow; R Joyce Verburgh; Geert van Amerongen; Selma Yüksel; D Tien Nguyen; Stephen McQuaid; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

10.  Measles immune suppression: lessons from the macaque model.

Authors:  Rory D de Vries; Stephen McQuaid; Geert van Amerongen; Selma Yüksel; R Joyce Verburgh; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.